Cargando…

Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer

Using an electrochemiluminescence immunoassay, CYFRA 21-1 concentrations were measured in sera from 187 patients with primary liver cancer (164 with hepatocellular carcinoma (HCC) and 23 with intrahepatic cholangiocarcinoma (ICC)) and 87 patients with benign liver diseases. Concentrations of CYFRA 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uenishi, T, Kubo, S, Hirohashi, K, Tanaka, H, Shuto, T, Yamamoto, T, Nishiguchi, S
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2741125/ https://www.ncbi.nlm.nih.gov/pubmed/12799633 http://dx.doi.org/10.1038/sj.bjc.6601026

Ejemplares similares

Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer
por: Boeck, S, et al.
Publicado: (2013)

Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma
por: Caviglia, Gian Paolo, et al.
Publicado: (2020)

Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.
por: Takada, M., et al.
Publicado: (1995)

Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma
por: Kummar, S, et al.
Publicado: (2002)

Clinical Usefulness of CYFRA Assay in Diagnosing Lung Cancer: Measurement of Serum Cytokeratin Fragment
por: Sugama, Yasuo, et al.
Publicado: (1994)

Role of serum cytokeratin 19 fragment (Cyfra 21.1) as a prognostic biomarker in patients with differentiated thyroid cancer
por: Giovanella, L., et al.
Publicado: (2017)

Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer
por: Xu, Youtao, et al.
Publicado: (2015)

Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer
por: Nakata, B, et al.
Publicado: (2004)

New Immunosensing-Fluorescence Detection of Tumor Marker Cytokeratin-19 Fragment (CYFRA 21-1) Via Carbon Quantum Dots/Zinc Oxide Nanocomposite
por: Alarfaj, Nawal Ahmed, et al.
Publicado: (2020)

Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy
por: Hanke, B, et al.
Publicado: (2003)

Decreased levels of serum cytokeratin 19 fragment CYFRA 21-1 predict objective response to chemotherapy in patients with non-small cell lung cancer
por: PANG, LI, et al.
Publicado: (2013)

Role of Cytokeratin 20 as a Predictive and Prognostic Marker in Urothelial Neoplasms
por: Popov, Hristo, et al.
Publicado: (2022)

Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers
por: Brenner, B, et al.
Publicado: (2002)

Prognostic significance of dysadherin expression in advanced colorectal carcinoma
por: Aoki, S, et al.
Publicado: (2003)

Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to α-fetoprotein
por: Cui, R, et al.
Publicado: (2003)

Antibodies to CD20 and MHC class II antigen bound to B-lymphoma cells accumulate in shed cytoplasmic fragments
por: Michel, R B, et al.
Publicado: (2004)

Role of biological markers in the clinical outcome of colon cancer
por: Nanni, O, et al.
Publicado: (2002)

Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients
por: Bachelot, T, et al.
Publicado: (2003)

The Ki67 index a prognostic marker in medullary thyroid carcinoma
por: Tisell, L E, et al.
Publicado: (2003)

ErbB2 and bone sialoprotein as markers for metastatic osteosarcoma cells
por: Valabrega, G, et al.
Publicado: (2003)

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
por: Faneyte, I F, et al.
Publicado: (2003)

Apoptosis control and proliferation marker in human normal and neoplastic adrenocortical tissues
por: Bernini, G P, et al.
Publicado: (2002)

Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
por: Watson, P H, et al.
Publicado: (2003)

Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma
por: Ueno, T, et al.
Publicado: (2003)

Lung tumour markers in oncology practice: a study of TPA and CA125
por: Buccheri, G, et al.
Publicado: (2002)

CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL
por: Cutrona, G, et al.
Publicado: (2002)

Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer
por: Sauter, E R, et al.
Publicado: (2002)

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients
por: Kristiansen, G, et al.
Publicado: (2003)

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
por: Weigelt, B, et al.
Publicado: (2003)

Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?
por: Cooper, R, et al.
Publicado: (2003)

Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics
por: Broutet, N, et al.
Publicado: (2003)

Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker
por: Salazar-Onfray, F, et al.
Publicado: (2002)

The effect of cigarette smoking use and cessation on serum insulin-like growth factors
por: Renehan, A G, et al.
Publicado: (2004)

Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR
por: Gal, S, et al.
Publicado: (2004)

Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples
por: Thomas, D S, et al.
Publicado: (2015)

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
por: Boulay, J-L, et al.
Publicado: (2002)

Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis
por: Wang, W, et al.
Publicado: (2004)

Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers
por: Weigelt, B, et al.
Publicado: (2004)

Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma
por: Werther, K, et al.
Publicado: (2002)

Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia
por: Stessels, F, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_e1omvaprb8h6u9v6as3uj4v0br